The U.S. prevention of cardiovascular disease guidelines and implications for implementation in LMIC

Area of Science:

• Public Health
• Cardiovascular Medicine
• Global Health Policy

Background:

• Recent US cardiovascular disease (CVD) prevention guidelines (2013 ACC/AHA, 2014 JNC8) focus on risk assessment, lifestyle, obesity, cholesterol, and hypertension.
• These guidelines have limited recognition and consideration in lower- and middle-income countries, despite 80% of the global CVD burden occurring there.
• Effective CVD risk detection and management strategies are needed in developing nations.

Purpose of the Study:

• To highlight the need for adapting international CVD prevention guidelines for developing countries.
• To emphasize the importance of context-specific strategies for CVD risk management in resource-limited settings.
• To advocate for global CVD prevention standards and rapid guideline adaptation to meet World Health Organization 2025 targets.

Main Methods:

• Review and analysis of existing US cardiovascular disease prevention guidelines.
• Assessment of the applicability and limitations of these guidelines in lower- and middle-income country contexts.
• Discussion of the global burden of CVD and the necessity for tailored public health interventions.

Main Results:

• Current US guidelines may not be fully implementable globally due to differences in local epidemiology and available resources.
• A significant portion of CVD prevention recommendations require modification to be effective in developing countries.
• Global CVD prevention standards and adapted guidelines are essential for progress.

Conclusions:

• Adapting international CVD prevention guidelines to local contexts in developing countries is critical.
• Tailored strategies are necessary to effectively reduce the global burden of cardiovascular disease.
• Global collaboration and guideline dissemination are key to achieving international health goals.